+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Nottingham Prognostic Index is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer



Nottingham Prognostic Index is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer



Asian Pacific Journal of Cancer Prevention 20(1): 59-63



Introduction: Triple-negative breast cancer (TNBC) is characterized by a poor prognosis due to high mortality

(PDF emailed within 1 workday: $29.90)

Accession: 066120375

Download citation: RISBibTeXText

PMID: 30678381


Related references

Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?. Bmc Cancer 11: 299, 2012

A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age. Journal of Breast Cancer 20(1): 65-73, 2017

Prognostic significance of Nottingham Prognostic Index in non-metastatic breast cancer. Journal of B.U.On. 21(1): 279, 2016

Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index. Supportive Care in Cancer 18(12): 1553-1564, 2011

HER-2 overexpression in node negative breast cancer Prognostic significance and comparison with the Nottingham Prognostic Index. Breast Cancer Research & Treatment 69(3): 264, 2001

Determination of cell polarity as indicated by CD66a expression pattern, improves the prognostic impact of the Nottingham prognostic index in node-negative breast cancer patients. Breast Cancer Research & Treatment 57(1): 100, 1999

The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment. Plos One 10(11): E0143537, 2016

Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer. Bmc Cancer 16(1): 833, 2016

Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer. Biomedicine & PharmacoTherapy 60(6): 293-297, 2006

Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. Clinical Cancer Research 12(8): 2468-2475, 2006

Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution. Surgery Today 35(11): 907-911, 2005

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. Journal of Pathology. Clinical Research 2(1): 32-40, 2016

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. British Journal of Cancer 85(6): 795-797, 2001

Notice of retraction. Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution. Surgery Today 39(8): 738-738, 2009

The nottingham prognostic index npi a combination of multiple prognostic factors derived from the nottingham england uk tenovus primary cancer study. Laboratory Investigation 64(1): 11A, 1991